RVP logo

RETRACTABLE TECHNOLOGIES INC

RVPNYSE AMERICAN
πŸ† #3620 by market capUS Equity
$348.40β–² $7.35 (+2.11%)
Simulated price
1hβ€”
24hβ–² 2.1%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$20M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+10.1%
Healthy
πŸ“ŠGross Margin
-2.1%
Thin
πŸ’΅FCF Margin
25.3%
Strong
βš–οΈP/S Ratio
0.5x
Cheap
Otter Score
57
Weak
No chart data available for RVP.

Trading Snapshot

Day Range
$343.20 – $353.53
52-Week Range
$0.60 – $1.14
Volume
$3.02B
Avg Volume
$3.65B
Shares Outstanding
29.9M
Next Earnings
Oct 4, 2026

Fundamentals Snapshot

Annual Revenue
$38M
Last Q Revenue
$7M
P/E Ratio
β€”
P/S Ratio
0.5x
EPS (TTM)
$-0.21
Dividend Yield
1.14%

Why Investors Own RVP

  • βœ“High-growth profile β€” revenue up -9.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 37% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$38Mβ–Ό βˆ’8.1% YoY
Gross Margin (TTM)
36.6%β–² +1.9% YoY
Operating Income (TTM)
$10Mβ–Ό βˆ’8.1% YoY
Free Cash Flow (TTM)
$8Mβ–Ό βˆ’8.1% YoY

About RETRACTABLE TECHNOLOGIES INC

Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
57/100

Analyst Price Target

β“˜
Average Target
$376.55
β–² +8.1% Upside
High Target$427.14
Low Target$319.05
Based on 26 analysts

Latest News & Updates